Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extension Study of P1101 in Japanese Patients Who Have Completed Phase 2 Single Arm Study in Polycythemia Vera (PV) Patients (Study A19-201) or Phase 3 Study in Essential Thrombocythemia (ET) Patients (Study P1101 ET)

NCT04655092 is registered in ClinicalTrials.gov with PharmaEssentia Japan K.K. as lead sponsor.

NCT NCT04655092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04655092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extension Study of P1101 in Japanese Patients Who Have Completed Phase 2 Single Arm Study in Polycythemia Vera (PV) Patients (Study A19-201) or Phase 3 Study in Essential Thrombocythemia (ET) Patients (Study P1101 ET)
Lead sponsor
PharmaEssentia Japan K.K.
Phase
Phase 3
Overall status
Recruiting
Start date
January 19, 2021
Completion date
June 30, 2026
Enrollment
67 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

polycythemia vera (pv)